about
Vapor of volatile oils from Litsea cubeba seed induces apoptosis and causes cell cycle arrest in lung cancer cellsReal-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodesConfirmation of gene expression-based prediction of survival in non-small cell lung cancerApplication of serum SELDI proteomic patterns in diagnosis of lung cancerTargeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerManagement of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalRole of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patientsChemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancerAurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosisExtracorporeal support for pulmonary resection: current indications and resultsFoxM1: a novel tumor biomarker of lung cancerLysyl oxidase: a lung adenocarcinoma biomarker of invasion and survivalXPC mRNA level may predict relapse in never-smokers with non-small cell lung cancersOct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cellsRole of chaperone mediated autophagy (CMA) in the degradation of misfolded N-CoR protein in non-small cell lung cancer (NSCLC) cellsAn NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancerFrondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasisInhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung AdenocarcinomaDisparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study.Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer.Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling.Increasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancerCorrelation of genes associated with drug response to prognosis of large cell lung carcinoma.p53 is an important factor for the radiosensitization effect of 2-deoxy-D-glucoseA small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung CancerTriggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model.Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migrationProposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease.Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.Prognostic value of CD44 expression in non-small cell lung cancer: a systematic reviewExpression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features.PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapyMicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.
P2860
Q21090858-0EDD918B-D86D-44DA-A4EF-051718F5C398Q22306471-9A06E8ED-747F-46CB-A000-A17E325B29EEQ23918759-8B7BD425-5ADB-4726-83B7-944F98CC6651Q24810545-B6EE1431-8BEC-4E15-B0D2-64B130FEAB42Q26743378-CD4429F6-2790-4B1E-B3F4-6587110DA540Q26853543-770FEFCE-5707-4C8D-B293-8015C57D0974Q26866485-CE5046E6-FF1E-4B84-B401-1EFDEEEDA03CQ26998615-D588FEFA-90A4-40FB-9D52-784E97795AB2Q27853047-B7743390-A77B-4741-B059-59AE5893F9CCQ28070761-C8EF472A-4F5D-4F4A-A69C-09385401F572Q28081689-128B1AB5-2FCB-491B-98CE-388D99B718FDQ28236372-EAA7C23F-F37C-4F47-81BE-DD0640FBF171Q28246216-E234E779-2276-4F27-89B9-329875CF62D9Q28473082-32BBBB14-FA7C-462A-942E-3C4E34E7672EQ28477214-C0AE14CC-3583-40BB-BB9F-011E977B6069Q28481620-706AB092-3A90-456F-9155-EC78B08D4772Q28484906-5477F1F2-6D32-4EBD-8517-CD3AB4570055Q28534136-1150DCD0-5C4F-4C22-A5B9-E6D6F6E41625Q28547292-B2ABBAC1-7CAB-474A-8EAD-1F6CF16AF670Q30500194-1C4D6FE4-785E-4F3A-B51A-E19ACE19578EQ30951893-A7121C57-0CC3-4793-ABE4-FA831E7D947EQ31039610-357E4BE1-BB71-497C-97A9-16AA6BAEC07FQ33499899-533C46C3-8923-4170-A695-1D3D1831C23CQ33554024-993D36F7-C874-41FF-8DBB-71F7AD7814E7Q33579763-0A6417B1-35BE-459C-90A2-A34C863FFCFCQ33586467-90214BB4-66D4-4989-ADC4-97F5E3D89DF8Q33620098-E4E22911-2393-49A6-B3F8-6D047D81BA82Q33635117-1EFDB41A-6FAB-4C77-8AAD-ACBCD00B5F89Q33682155-33A82E30-C030-4F60-8543-CEEEBCFAD7FFQ33717981-C32E554D-2200-450A-B42D-6E070A37F94EQ33747929-E8E6FFB1-0E1A-45FA-9C43-D3F3E0E0DC37Q33755300-5D39AAE2-A368-4770-9A3B-B95384ABCB28Q33759458-B77C12C8-44C0-47DB-9A94-494BC12AA2DAQ33804283-051FDEF9-470B-4024-925F-086C97D5E77BQ33861078-86C152BD-8EE3-492D-845D-C939D5133616Q33932016-B5C1594B-7C57-4DEC-8142-C6CD23847AC8Q34028901-95FA40EF-7169-4598-9752-0B729A15380FQ34066293-10A53A65-7568-42FC-9B71-4E49DE972C2FQ34186755-67C0AE65-A604-4C86-B340-99B08D9EEBA4Q34271306-A39F2398-72CB-47DF-ACEB-1FCA1EC9D059
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Multidisciplinary management of lung cancer.
@ast
Multidisciplinary management of lung cancer.
@en
type
label
Multidisciplinary management of lung cancer.
@ast
Multidisciplinary management of lung cancer.
@en
prefLabel
Multidisciplinary management of lung cancer.
@ast
Multidisciplinary management of lung cancer.
@en
P356
P1476
Multidisciplinary management of lung cancer.
@en
P2093
Alexander Spira
David S Ettinger
P304
P356
10.1056/NEJMRA035536
P407
P577
2004-01-01T00:00:00Z